Type and hit ENTER

News

All the posts published.

Dr Darragh McCafferty, ProAxsis’ Head of Assay Development, will be presenting new data on the company’s ongoing project to develop a …

November 15, 2021

Our CEO, Dr David Ribeiro, will be attending the DxPx Conference, taking place face-to-face in Dusseldorf and in a virtual format, …

November 4, 2021

ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN …

October 20, 2021

ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it has been awarded funding for a high impact development project from …

October 13, 2021

ProAxsis are delighted to announce that the company will be presenting results from several recent projects at the European Respiratory Society …

September 3, 2021

York and Belfast, UK (August 19th, 2021) – Aptamer Group, the developer of custom affinity ligands to enable the life science …

August 19, 2021

As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce two new appointments within …

June 21, 2021

ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it has entered into an exclusive licensing agreement with …

June 7, 2021

Introduction In parallel with the release of the company’s 2020 financial statements, I am pleased to provide an associated update on …

May 21, 2021

ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of Geneva and the University Hospital of Geneva, today …

February 21, 2021
News Archives - ProAxsis